|

A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.

RECRUITINGSponsored by Zhujiang Hospital
Actively Recruiting
SponsorZhujiang Hospital
Started2023-10-01
Est. completion2025-04-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06082284

Summary

By using a highly sensitive serum M protein detection method based on the MALDI-TOF MS platform, serum monoclonal immunoglobul (M protein) in detection was performed on the visiting patients to explore the positive rate of serum M protein and its distribution in different departments. And exploring the correlation analysis between the relative concentration of serum M protein based on the above highly sensitive methods and clinical indicators.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients attending the outpatient/emergency/inpatient department of Zhujiang Hospital;
* Age: over 18 years old;
* There are sufficient remaining serum samples and extensive informed consent has been signed.

Exclusion Criteria:

* Early diagnosis of hematological diseases such as plasma cell or other B lymphocyte proliferative diseases；
* Improper storage or repeated freeze-thaw of remaining serum samples.

Conditions3

CancerM-ProteinMultiple Myeloma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.